Correlations between p53 and CD44 expression have been established in cancer cells, suggesting that mutant p53 might be able to target CD44 as a gene, leading to the progression of AD via the regulation of neuronal ferroptosis (Uberti et al., 2010). This evidence concerns the gene TP53 and Alzheimer disease.